Le Lézard
Classified in: Tourism and vacations, Business, Covid-19 virus
Subject: ERN

Lakeview Hotel Investment Corp Announces First Quarter 2021 Results


WINNIPEG, AB, June 15, 2021 /CNW/ - Lakeview Hotel Investment Corp ("LHIC") is pleased to report its financial results for the Quarter ended March 31, 2021.  The following comments in regard to the financial results should be read in conjunction with the March 31, 2021 financial statements and Management Discussion and Analysis which are available on the SEDAR website www.sedar.com.

The COVID-19 pandemic continues to have an adverse effect on the Company's operating business due to a decline in both leisure and business travel and economic activity.  The effect on specific regions has been dependant on government responses to the pandemic affecting the operation of the hotel industry including the requirement of travel restrictions and the closure and reduced occupancy allowed in hotel restaurants.

We expect that there will be an ultimate recovery of the travel industry and local economic activity in the regions that our hotels are located, but expect that the lower than normal results will continue for several more quarters until the population is vaccinated and provincial restrictions are lifted.

Following is a comparison of the operating results for the three months ended March 31, 2021 and the comparable period in 2020:


Three months ended
March 31


2021

2020


$

$

Hospitality Revenue



Room

1,332,497

1,875,258

Food & Beverage

242,731

437,892

Other

377,572

125,398

Total Revenue

1,952,800

2,438,548

Expenses

(3,652,449)

(5,002,145)

Net Loss

(1,699,649)

(2,563,597)

Basic and diluted net loss per share

(0.087)

(0.131)

Reconciliation to funds from operations



Add (deduct)



Amortization of income properties

71,169

87,504

Amortization of franchise fees

-

4,117

Provision for impairment of income properties

-

328,513

Income from Lakeview Flag Licensing General Partnership

(14,762)

(67,131)

Income from Lakeview Flag Management General Partnership

-

(26,918)

Funds from operations

(1,643,242)

(2,237,512)

Basic and diluted funds from operations per share

(0.084)

(0.114)

Contributions to reserve account

(30,461)

(39,572)

Adjusted funds from operations

(1,673,703)

(2,277,084)

Basic and diluted adjusted funds from operations per share

(0.086)

(0.116)




Lakeview Hotel Investment Corp is listed on the TSX Venture Exchange under the symbol "LHR".  Lakeview Hotel Investment Corp received income from ownership, management and licensing of hotel properties.

The TSX Venture Exchange nor its Regulation Service Provider (as the term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

View original content: http://www.newswire.ca/en/releases/archive/May2019/30/c8567.html

%SEDAR: 00034072E

SOURCE Lakeview Hotel Investment Corp


These press releases may also interest you

at 11:05
Parsec Automation Corp. has been recognized by the American Business Awards® ("Stevie Awards®") for its significant contributions to progress in the manufacturing industry and commitment to going above and beyond for its customers. The company was...

at 11:00
IPv4.Global, the world's largest, most-trusted and transparent IPv4 marketplace, today announced it was named the winner of a Silver Stevie® Award in the Fastest Growing Company of the Year - Up to 100 Employees category in The 22nd Annual American...

at 10:52
Today, The Bronx Social Care Network (BSCN), a coalition of Bronx-based federally qualified community health centers (FQHCs) partnering with more than 50 Bronx-based community-based organizations (CBOs), led by Urban Health Plan, one of the largest...

at 10:15
More automation and artificial intelligence integration, improved capabilities for virtual and hybrid events, and an emphasis on data-driven insights and personalisation are what the Event Management Software Market will see in the future....

at 10:12
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that results from the ibezapolstat Phase 2 clinical...

at 10:05
Gibson, Dunn & Crutcher LLP and Barrasso Usdin Kupperman Freeman & Sarver, LLC announce the filing of a civil rights action on behalf of Tayjha Alfred against Martin Bofill ("Bo") Duhé, the District Attorney for the 16th Judicial District of...



News published on and distributed by: